Carlos A. Zarate

52.3k total citations · 12 hit papers
481 papers, 35.6k citations indexed

About

Carlos A. Zarate is a scholar working on Pharmacology, Biological Psychiatry and Psychiatry and Mental health. According to data from OpenAlex, Carlos A. Zarate has authored 481 papers receiving a total of 35.6k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Pharmacology, 198 papers in Biological Psychiatry and 187 papers in Psychiatry and Mental health. Recurrent topics in Carlos A. Zarate's work include Treatment of Major Depression (246 papers), Tryptophan and brain disorders (198 papers) and Bipolar Disorder and Treatment (153 papers). Carlos A. Zarate is often cited by papers focused on Treatment of Major Depression (246 papers), Tryptophan and brain disorders (198 papers) and Bipolar Disorder and Treatment (153 papers). Carlos A. Zarate collaborates with scholars based in United States, Czechia and United Kingdom. Carlos A. Zarate's co-authors include Husseini K. Manji, David A. Luckenbaugh, Rodrigo Machado‐Vieira, Nancy E. Brutsché, Dennis S. Charney, Jaskaran Singh, Ioline D. Henter, Mauricio Tohen, Allison C. Nugent and Rezvan Ameli and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Carlos A. Zarate

464 papers receiving 34.6k citations

Hit Papers

A Randomized Trial of an N-methyl-D-aspartate Antagonist ... 2006 2026 2012 2019 2006 2016 2007 2018 2010 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
    2006 2.7k citations Carlos A. Zarate, Nancy E. Brutsché et al. profile →
  2. NMDAR inhibition-independent antidepressant actions of ketamine metabolites
    2016 1.1k citations Ruin Moaddel, Peixiong Yuan et al. profile →
  3. Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
    2007 921 citations Carlos A. Zarate et al. Biological Psychiatry profile →
  4. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
    2018 816 citations Ruin Moaddel, Carlos A. Zarate et al. profile →
  5. A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
    2010 734 citations Nancy E. Brutsché, David A. Luckenbaugh et al. profile →
  6. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
    2008 683 citations Carlos A. Zarate et al. profile →
  7. Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
    2012 607 citations Carlos A. Zarate, Nancy E. Brutsché et al. Biological Psychiatry profile →
  8. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
    2017 476 citations Elizabeth D. Ballard, Carlos A. Zarate et al. profile →
  9. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
    2016 334 citations Mark J. Niciu, Elizabeth D. Ballard et al. Biological Psychiatry profile →
  10. Prognosis and improved outcomes in major depression: a review
    2019 285 citations Christoph Kraus, Bashkim Kadriu et al. profile →
  11. Depression in the Primary Care Setting
    2019 281 citations Lawrence T. Park, Carlos A. Zarate profile →
  12. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
    2020 254 citations Carlos A. Zarate et al. Journal of Affective Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos A. Zarate United States 99 17.0k 15.1k 10.6k 10.4k 6.3k 481 35.6k
Husseini K. Manji United States 88 9.6k 0.6× 9.9k 0.7× 7.0k 0.7× 9.9k 1.0× 4.1k 0.7× 222 27.7k
Wayne C. Drevets United States 109 9.2k 0.5× 9.7k 0.6× 10.8k 1.0× 10.0k 1.0× 19.6k 3.1× 352 47.0k
Gerard Sanacora United States 72 8.3k 0.5× 9.0k 0.6× 3.1k 0.3× 8.6k 0.8× 4.3k 0.7× 192 21.6k
Philip J. Cowen United Kingdom 87 6.6k 0.4× 4.4k 0.3× 5.2k 0.5× 8.3k 0.8× 7.9k 1.3× 608 29.2k
David A. Luckenbaugh United States 72 8.2k 0.5× 6.9k 0.5× 6.0k 0.6× 4.7k 0.4× 3.6k 0.6× 159 17.9k
Alan F. Schatzberg United States 87 7.4k 0.4× 5.9k 0.4× 6.8k 0.6× 3.3k 0.3× 10.8k 1.7× 421 34.1k
Alessandro Serretti Italy 75 5.8k 0.3× 4.4k 0.3× 9.0k 0.9× 4.3k 0.4× 3.2k 0.5× 738 26.4k
Herbert Y. Meltzer United States 104 5.4k 0.3× 7.8k 0.5× 19.8k 1.9× 15.8k 1.5× 5.1k 0.8× 839 46.1k
Ronald S. Duman United States 128 12.4k 0.7× 19.1k 1.3× 4.7k 0.4× 28.9k 2.8× 8.5k 1.4× 365 61.7k
Oliver Howes United Kingdom 85 3.0k 0.2× 5.3k 0.4× 11.8k 1.1× 6.8k 0.7× 7.5k 1.2× 435 27.7k

Countries citing papers authored by Carlos A. Zarate

Since Specialization
Citations

This map shows the geographic impact of Carlos A. Zarate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos A. Zarate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos A. Zarate more than expected).

Fields of papers citing papers by Carlos A. Zarate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos A. Zarate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos A. Zarate. The network helps show where Carlos A. Zarate may publish in the future.

Co-authorship network of co-authors of Carlos A. Zarate

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos A. Zarate. A scholar is included among the top collaborators of Carlos A. Zarate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos A. Zarate. Carlos A. Zarate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brenna, Connor T. A., Benjamin I. Goldstein, Carlos A. Zarate, & Beverley A. Orser. (2024). Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care. Anesthesiology. 141(2). 222–237. 10 indexed citations
2.
Greenstein, Deanna, et al.. (2024). Long-term follow-up of participants in ketamine clinical trials for mood disorders. Journal of Affective Disorders. 357. 134–137. 6 indexed citations
3.
Nugent, Allison C., Alicia A. Livinski, Ioline D. Henter, et al.. (2024). Exploring the impact of music on response to ketamine/esketamine: A scoping review. Neuroscience & Biobehavioral Reviews. 162. 105693–105693. 7 indexed citations
4.
Johnston, Jenessa N., Ioline D. Henter, Christoph Kraus, et al.. (2023). Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile. Drug Discovery Today. 28(4). 103518–103518. 41 indexed citations
5.
Mkrtchian, Anahit, Jennifer W. Evans, Christoph Kraus, et al.. (2020). Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Molecular Psychiatry. 26(7). 3292–3301. 72 indexed citations
6.
Greenstein, Dede, et al.. (2019). Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression. Journal of Affective Disorders. 263. 568–575. 67 indexed citations
7.
Gilbert, Jessica R., et al.. (2019). Magnetoencephalographic Correlates of Suicidal Ideation in Major Depression. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 5(3). 354–363. 22 indexed citations
8.
Saligan, Leorey N., Cristan Farmer, Elizabeth D. Ballard, Bashkim Kadriu, & Carlos A. Zarate. (2018). Disentangling the association of depression on the anti-fatigue effects of ketamine. Journal of Affective Disorders. 244. 42–45. 13 indexed citations
9.
Nugent, Allison C., Elizabeth D. Ballard, Todd D. Gould, et al.. (2018). Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Molecular Psychiatry. 24(7). 1040–1052. 167 indexed citations
10.
Niciu, Mark J., Bridget Shovestul, Cristan Farmer, et al.. (2018). Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. Journal of Affective Disorders. 232. 310–315. 97 indexed citations
11.
Evans, Jennifer W., Níall Lally, Li An, et al.. (2018). 7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study. Neuropsychopharmacology. 43(9). 1908–1914. 36 indexed citations
12.
Henter, Ioline D., RAFAEL TEIXEIRA DE SOUSA, & Carlos A. Zarate. (2018). Glutamatergic Modulators in Depression. Harvard Review of Psychiatry. 26(6). 307–319. 68 indexed citations
13.
Sinyor, Mark, Marissa Williams, Beverley A. Orser, et al.. (2018). Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting. Journal of Affective Disorders. 241. 103–109. 24 indexed citations
14.
Duncan, Wallace C., Elizabeth E. Slonena, Nadia S. Hejazi, et al.. (2017). Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine’s Rapid Antidepressant Properties. Biological Psychiatry. 82(5). 361–369. 65 indexed citations
15.
Bernert, Rebecca A., et al.. (2016). Sleep architecture parameters as a putative biomarker of suicidal ideation in treatment-resistant depression. Journal of Affective Disorders. 208. 309–315. 55 indexed citations
16.
Park, Minkyung, Laura Newman, Philip W. Gold, et al.. (2016). Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression. Journal of Psychiatric Research. 84. 113–118. 73 indexed citations
17.
Tohen, Mauricio, Paola Salvatore, Carlos A. Zarate, et al.. (2016). The McLean-Harvard First-Episode Project. The Journal of Clinical Psychiatry. 77(6). 781–788. 14 indexed citations
18.
Nugent, Allison C., Stephen E. Robinson, Richard Coppola, Maura L. Furey, & Carlos A. Zarate. (2015). Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder. NeuroImage. 118. 1–12. 64 indexed citations
19.
Ballard, Elizabeth D., Dawn F. Ionescu, Jennifer L. Vande Voort, et al.. (2014). Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt. Journal of Affective Disorders. 162. 34–38. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Husseini K. Manji Breakdown of academic impact, for papers by Wayne C. Drevets Breakdown of academic impact, for papers by Gerard Sanacora Breakdown of academic impact, for papers by Philip J. Cowen Breakdown of academic impact, for papers by David A. Luckenbaugh Breakdown of academic impact, for papers by Alan F. Schatzberg Breakdown of academic impact, for papers by Alessandro Serretti Breakdown of academic impact, for papers by Herbert Y. Meltzer Breakdown of academic impact, for papers by Ronald S. Duman Breakdown of academic impact, for papers by Oliver Howes
Rankless by CCL
2026